|
業務類別
|
-- |
|
業務概覽
|
Yichang HEC ChangJiang Pharmaceutical Co Ltd functions in the Chinese drug industry. As a domestic manufacturing wing of the HEC Group, Yichang employs its therapeutic technology to address viral, endocrine, metabolic and cardiovascular diseases. The company's major revenue driver is the anti-viral product division, which manufactures its key product, Kewei. It is one of the leading products in China's anti-influenza market. Its other products include Ertongshu, Oumeining, Xinhaining, and Xining which cure diseases such as hypertension and allergy. |
| 公司地址
| No. 38 Binjiang Road, Yidu, Hubei Province, Yichang, CHN |
| 電話號碼
| -- |
| 傳真號碼
| -- |
| 公司網頁
| http://www.hec-changjiang.com |
| 員工數量
| 4861 |
| Mr. Juncai Jiang |
Director and General Manager |
-- |
26/04/2024 |
| Mr. Danjin Wang |
Director and Deputy General Manager |
-- |
26/04/2024 |
| Mr. Shuang Li |
Director and Deputy General Manager |
-- |
26/04/2024 |
| Mr. Hao Chen |
Director and General Manager, Sales |
-- |
26/04/2024 |
|
|
| Mr. Xinfa Tang |
Chairman of the Board |
26/04/2024 |
| Mr. Juncai Jiang |
Director and General Manager |
26/04/2024 |
| Mr. Danjin Wang |
Director and Deputy General Manager |
26/04/2024 |
| Mr. Shuang Li |
Director and Deputy General Manager |
26/04/2024 |
| Mr. Jianxin Tang |
Independent Director |
26/04/2024 |
| Ms. Ling Xiang |
Independent Director |
26/04/2024 |
| Mr. Xuechen Li |
Independent Director |
26/04/2024 |
| Mr. Hao Chen |
Director and General Manager, Sales |
26/04/2024 |
|
|
|
|
